Hypertension | Treatment Algorithms: Claims Data Analysis | US | 2017
Hypertension is a chronic condition that can be effectively managed by a vast array of drugs, spanning many drug classes. The antihypertensive market is highly mature and most of its drug classes are saturated with generics. Further, the market is characterized by the presence of numerous fixed dose combinations (FDCs) and only a handful of agents devoid of direct generic competition. The Hypertension Treatment Algorithm provides insights into drug class prescribing patterns among a wealth of treatment options, where owing to the high availability of generics, pricing pressures are of minimal concern.
Related Market Assessment Reports
Report
Chronic Obstructive Pulmonary Disease – Unmet Need – Unmet Need – Severe to Very Severe Chronic Obstructive Pulmonary Disease (US EU)
The severe to very severe chronic COPD market is crowded, with numerous LAMA, LABA/ICS, LABA/LAMA, and triple LABA/LAMA/ICS inhalers competing for use. Although dual and triple longacting…
Report
Diabetic Macular Edema / Diabetic Retinopathy – Current Treatment – Treatment Algorithms: Claims Data Analysis – Diabetic Macular Edema (US)
Diabetic macular edema (DME) is a serious complication of diabetic retinopathy caused by persistently elevated blood glucose levels. Without timely treatment, DME can progress to significant vision…
Report
Multiple System Atrophy – Unmet Need – Multiple System Atrophy (US/EU) – Unmet Need – Multiple System Atrophy (US/EU)
Multiple system atrophy (MSA) is a rare, rapidly progressing neurodegenerative synucleinopathy that disrupts movement, balance, and autonomic function. Current management comprises only symptomatic…
